Coissac Patrice

CIK 00013412121 companyCHESHIRE, CT

SEC Profile

Transactions

Companies

Filings

CIK

0001341212

Recent Transactions

46 trades

Sale
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2012-10-31$92.18/sh−12,030→ 1,118 total
Sale
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2012-10-31$91.15/sh−39,188→ 13,148 total
Sale
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2012-10-31$90.80/sh−33,546→ 52,336 total
Sale
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2012-08-28$106.37/sh−21,551→ 85,882 total
Exercise/Conversion
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2012-08-28$42.66/sh+21,551→ 107,433 total
Exercise/Conversion
ALEXION PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2012-08-28−21,551→ 56,251 total
Exercise/Conversion
ALEXION PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2012-08-27−29,734→ 37,500 total
Exercise/Conversion
ALEXION PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2012-08-27−12,198→ 77,802 total
Exercise/Conversion
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2012-08-27$42.66/sh+12,198→ 127,814 total
Sale
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2012-08-27$107.05/sh−41,932→ 85,882 total
Exercise/Conversion
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2012-08-27$22.90/sh+29,734→ 115,616 total
Exercise/Conversion
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2012-02-23$17.65/sh+90,000→ 175,882 total
Exercise/Conversion
ALEXION PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2012-02-23−5,628→ 0 total
Exercise/Conversion
ALEXION PHARMACEUTICALS, INC.
Option to Purcahse Common Stock
2012-02-23−84,372→ 0 total
Sale
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2012-02-23$85.03/sh−90,000→ 85,882 total
Exercise/Conversion
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2012-02-03+8,000→ 85,882 total
Exercise/Conversion
ALEXION PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2012-02-03+64,000→ 64,000 total
Exercise/Conversion
ALEXION PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2011-11-16−40,000→ 0 total
Exercise/Conversion
ALEXION PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2011-11-16−32,766→ 67,234 total
Exercise/Conversion
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2011-11-16$22.90/sh+32,766→ 150,648 total
Sale
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2011-11-16$66.87/sh−72,766→ 77,882 total
Exercise/Conversion
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2011-11-16$11.92/sh+40,000→ 117,882 total
Sale
ALEXION PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2011-03-10−20,000→ 0 total
Sale
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2011-03-10$97.47/sh−45,000→ 38,941 total
Sale
ALEXION PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2011-03-10−7,094→ 0 total
Exercise/Conversion
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2011-03-10$16.35/sh+20,000→ 58,941 total
Exercise/Conversion
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2011-03-10$20.58/sh+25,000→ 83,941 total
Sale
ALEXION PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2011-02-17−16,000→ 0 total
Sale
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2011-02-17$93.25/sh−27,606→ 38,941 total
Exercise/Conversion
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2011-02-17$10.36/sh+16,000→ 91.041 total
Exercise/Conversion
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2011-02-17$14.08/sh+36,100→ 75,041 total
Sale
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2011-02-17$92.41/sh−24,494→ 66,547 total
Sale
ALEXION PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2011-02-17−36,100→ 0 total
Award
ALEXION PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2011-02-02+45,000→ 45,000 total
Award
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2011-02-02+5,000→ 38,941 total
Sale
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2010-10-27$67.18/sh−3,900→ 33,941 total
Sale
ALEXION PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2010-10-27−3,900→ 36,100 total
Exercise/Conversion
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2010-10-27$14.08/sh+3,900→ 37,841 total
Award
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2010-01-28+6,000→ 33,941 total
Award
ALEXION PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2010-01-28+50,000→ 50,000 total
Award
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2009-01-26+6,000→ 27,941 total
Award
ALEXION PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2009-01-26+45,000→ 45,000 total
Award
ALEXION PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2007-07-11+10,000→ 10,000 total
Award
ALEXION PHARMACEUTICALS, INC.
Option to Purchase Common Stock, par value $.0001
2006-06-07$32.70/sh+10,000→ 10,000 total
Award
ALEXION PHARMACEUTICALS, INC.
Option to Purchase Common Stock, par value $.0001
2006-01-09+8,000→ 8,000 total
Award
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001
2006-01-09$20.72/sh+3,000→ 13,000 total

Companies

ALEXION PHARMACEUTICALS, INC.
GM/President ALXN SAS Europe

Recent Filings

Address

C/O ALEXION PHARMACEUTICALS, INC 352 KNOTTER DRIVE

CHESHIRE, CT, 06410

View on SEC.gov